Overview

Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
To utilize the plasticity of the central pain pathways in order to (i) shift individuals with a pro-nociceptive pain modulation profile towards an anti-nociceptive one, and (ii) assess its relevance in minimizing pain-derived morbidity.
Phase:
N/A
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Duloxetine Hydrochloride
Pregabalin